Results 201 to 210 of about 261,983 (361)
Cofibrins and Fibrin-Intermediates as Indicators of Thrombin Activity in Vivo [PDF]
, 1960 John R. Shainoff +2 more
openalex +1 more source
Animal Models and Experimental Medicine, EarlyView.This study evaluates the role of elastin in vascular response 28 days after balloon angioplasty using uncoated and paclitaxel‐coated balloons in a healthy porcine model. The results show higher elastin content in external femoral arteries, which is inversely correlated with vascular injury, inflammation, smooth muscle cell loss, proteoglycan and fibrin
María Gracia de Garnica García +7 more
wiley +1 more source
Electron Microscope Observations on Intermediate Polymers in the Conversion of Fibrinogen to Fibrin
, 1953 Paul Kaesberg, Sidney Shulman
openalex +1 more source
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
Annals of Neurology, EarlyView.The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr. +2 more
wiley +1 more source
Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth. [PDF]
, 1967 J. F. Boyd
openalex +1 more source
Advanced NanoBiomed Research, EarlyView.Biomimetic microdevices are redefining anticancer drug screening by mimicking complex tumor microenvironments. This review highlights advances in microfluidic systems, cell microarrays, and in vivo‐like models, offering new insights into drug efficacy prediction and personalized medicine. The development of effective anticancer drugs remains a critical
Ching‐Te Kuo +2 more
wiley +1 more source
Fibrin breakdown products and fibrinolysis in renal disease [PDF]
, 1968 E. N. Wardle, Graeme Taylor
openalex +1 more source
Advanced NanoBiomed Research, EarlyView.The power of time‐of‐flight secondary ion mass spectrometry‐partial least square regression to detect interleukin‐8, a chemokine involved in inflammation and cancer, down to mass fractions of 1 ppm within biopolymer matrices, including Matrigel and glycosaminoglycan‐based hydrogels, is demonstrated.
Ralf Zimmermann +4 more
wiley +1 more source